ATLANTA–(BUSINESS WIRE)–Galt Pharmaceuticals announced the acquisition of a specialty branded product from Fortovia Therapeutics. Effective December 2, 2020, Galt added Oravig®, the first and only orally-dissolving buccal tablet for oral thrush, to its growing...
ATLANTA–(BUSINESS WIRE)–Pharmaceutical innovator Galt Pharmaceuticals announced a new drug approval to offer a non-opioid, non-controlled, non-addictive alternative for healthcare providers to manage patients suffering from pain. On July 8, 2020 the U.S. Food and Drug...
We use cookies to ensure that we give you the best experience on our website. To understand how the cookies are being used, please see our Privacy Policy or click OK to continue.OkPrivacy policy
